Insights

Two Bets, One Talent Pool: What April 2026 Means For UK AI

Two announcements in April reshaped the UK AI landscape. Here's what founders and investors should know.

Date

27.04.26

Author

Stefan Bozovic | CTO

On 16 April, the UK government took its first equity stake in a British AI company. Hours later, Anthropic told the world it would pay senior London engineers up to £630,000.

Same day. Same square mile. Two completely different bets on what UK AI looks like in five years.

What follows is what each side is actually offering, who they're competing for, and why the geography matters more than people are reading it.

The US bet

Anthropic has taken 158,000 sq ft in King's Cross, room for 800 people, up from a current UK headcount of around 200. OpenAI confirmed its first permanent London office three days earlier, also King's Cross, opening 2027. Perplexity took new King's Cross space in March. Decagon opened in November and is hiring across sales, deployment, and engineering.

The compensation tells you what these companies are actually buying. Anthropic's London ML research engineer roles list base salaries up to £630,000; total comp clears a million. Decagon has senior research roles at up to £300,000 base plus equity. None of them are building UK data centres. UK power prices have stalled the largest planned projects, and OpenAI paused its main UK data centre work last year. They're buying people.

"I need to raise a funding round sooner just to hire one senior person. When you have to hire, and you know OpenAI is next door, you have to be prepared to offer an insane package."

- London AI founder, quoted in The Times, April 2026

The UK bet

Sovereign AI launched the same day at Wayve's London office. The vehicle behaves like a venture firm, not a grant programme: it takes equity, secures rights of first refusal on follow-on rounds, and is run by people who do venture for a living. James Wise, a Balderton partner, chairs. Joséphine Kant, ex-Google and Y Combinator, runs selection.

The first equity ticket went to Callosum, a London infrastructure startup building orchestration software for heterogeneous chip architectures. Six others got AIRR access, the UK's national supercomputing network: Prima Mente (biological foundation models, Alzheimer's and Parkinson's), Cosine (sovereign coding models for defence and regulated sectors), Cursive (agentic AI, founded by senior DeepMind alumni), Doubleword (AI inference infrastructure), Twig Bio (engineering biology), and Odyssey (world models, defence and autonomous systems).

Each AIRR allocation runs up to one million GPU hours. Cosine's first 500,000 hours on Isambard-AI are worth millions in infrastructure value. Recipients also get ten cost-free visas with same-day decisions, government support on procurement and regulation, and in some cases Sovereign AI's right of first refusal on the next funding round.

Equity, compute, sovereignty. Not salary.

Same streets

Most of this sits inside a tight set of London neighbourhoods. Old Street holds around 24 AI companies, the highest density in the city. King's Cross has 10. Liverpool Street and Holborn make up most of the rest.

Kings Cross

Anthropic · OpenAI · DeepMind · Wayve · Isomorphic Labs

Prima Mente · Twig Bio · Odyssey

Old Street

Cosine · Cursive

Liverpool St

Callosum · Doubleword

Key

US giants

Sovereign AI cohort

Every Sovereign AI recipient sits inside these clusters. Prima Mente, Twig Bio, and Odyssey are in King's Cross, same blocks as Anthropic, OpenAI, Wayve, Google DeepMind, and Isomorphic Labs. Cosine and Cursive are in Old Street. Callosum and Doubleword are in Liverpool Street.

So what

The temptation is to read these as competing announcements. They aren't.

Anthropic and OpenAI are competing for senior individual contributors who can ship frontier work at scale. £630,000 is the price of anchoring that profile in London rather than San Francisco. Sovereign AI is competing for a different person: founders building companies that need sovereign-grade compute, regulated-sector access, and patient state capital to mature before a US hyperscaler can pre-empt them. The seven recipients are not generalist AI startups. They cluster in infrastructure, defence, agentic systems, and biology, the layers where the UK has decided to back national capability.

For founders, the structural question is which rail you're building on. The two routes ask for different products, different cap tables, different kinds of senior hire. Try to occupy both and the centre of gravity pulls you to one within two rounds.

For angels and investors, the seven Sovereign AI selections are a public statement about where one major UK capital allocator believes structural advantage sits. Salary inflation is the part of the picture that will show up first in portfolio reviews.

UK AI startups raised $7.9bn of VC in 2025, up from $4.4bn in 2024. Sovereign AI's £500m is additive to that base.

What to watch

Around 30 further firms are reportedly in discussion with Sovereign AI about AIRR access. The next allocations, and any equity tickets beyond Callosum, will indicate whether the Unit can move at the speed it has promised.

The harder test is retention. Sovereign AI's bet rests on the idea that compute, visas, and regulatory support are enough to anchor founders against the pull of US salaries and US venture markets. The next two to three years will tell us whether that holds.

The map has split in two. The streets haven't. Choosing which rail to build on, and which one to back, is part of the work now.

Sources

Sources: gov.uk press release, "AI firms pioneering drug discovery, cheaper supercomputing and more get first backing through UK's Sovereign AI" (16 April 2026); CNBC, Reuters, and Financial Times reporting on US AI companies expanding their London presence; The Times reporting on London AI salaries (April 2026); HSBC Innovation Banking UK and Dealroom UK Innovation Update (January 2026); company self-reported neighbourhood data.

Building the future of angel investing.

Investing in early-stage businesses involves significant risk, including illiquidity, dilution and the potential loss of capital. Investments should only be made as part of a diversified portfolio. Angels Den is intended solely for investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Access to investment opportunities is available only to registered members who have been assessed as suitable. All investments are made directly in the businesses presented. Information is provided by the businesses themselves, and Angels Den does not verify, endorse, or take responsibility for any statements, forecasts, opinions or outcomes. Nothing on this site constitutes investment, legal or tax advice, nor an offer or solicitation to buy or sell securities in any jurisdiction where such activity would be unlawful.

ST Albans, Hertfordshire, LONDON, UK AL1 1DT

©2026. All right reserved

CREATED BY BEFLUX.STUDIO